MedPath
HSA Approval

DBL POTASSIUM DIHYDROGEN PHOSPHATE CONCENTRATED INJECTION

SIN05856P

DBL POTASSIUM DIHYDROGEN PHOSPHATE CONCENTRATED INJECTION

DBL POTASSIUM DIHYDROGEN PHOSPHATE CONCENTRATED INJECTION

May 21, 1991

PFIZER PRIVATE LIMITED

PFIZER PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPFIZER PRIVATE LIMITED
Licence HolderPFIZER PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

B05XA06

potassium phosphate, incl. combinations with other potassium salts

Manufacturer Information

PFIZER PRIVATE LIMITED

Siegfried Hameln GmbH

Active Ingredients

Potassium Phosphate Monobasic (Potassium Dihydrogen phosphate)

1.361 g

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DBL POTASSIUM DIHYDROGEN PHOSPHATE CONCENTRATED INJECTION - HSA Approval | MedPath